Exploring Predictive Biomarkers and ERK1/2 Phosphorylation: A New Horizon in Forecasting Survival and Response to Immune Checkpoint Blockade in Glioblastoma Treatment
In this webinar, Victor Arrieta highlights the link between p-ERK activation and improved survival in rGBM patients using anti-PD-1 immunotherapy.
Overcoming Critical Issues in Glioblastoma Multiforme (GBM) Therapeutic Development
This article, originally published on Scientist.com, reviews the current standard of care for glioblastoma multiforme (GBM), challenges in developing accurate preclinical GBM models and effective therapies, and the future of GBM drug discovery.
#ExpertAnswers: Robert Doyle on Novel Drug Delivery Methods
Robert Doyle discusses novel drug delivery methods for basic research, drug discovery and development.
#ExpertAnswers: Christian Schnell on Drug Delivery Methods
Christian Schnell discusses novel drug delivery methods for basic research and novel infusion technologies.